Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0000950170-24-025921

SVP, CFO acquired 5,251 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Taylor Daphne SVP, CFO 2024-03-02 Option exercise +3,667 16,827 D
Taylor Daphne SVP, CFO 2024-03-04 Option exercise +1,584 18,411 D
Derivatives
Taylor Daphne SVP, CFO 2024-03-02 Option exercise · Restricted Stock Unit −3,667 7,333 D
Taylor Daphne SVP, CFO 2024-03-04 Option exercise · Restricted Stock Unit −1,584 1,583 D
Loading xslF345X05/ownership.xml…